95% CI, 6-16.9), at least 10% (OR = 11.3
Gmez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al
During treatment: Regular review appointments (typically every 36 months for diabetes, more frequently during dose titration) should include enquiry about mood and psychological wellbeing Healthcare professionals may use brief screening questions such as the PHQ-2 ("Over the past two weeks, how often have you felt down, depressed, or hopeless?" and "How often have you had little interest or pleasure in doing things?"), followed by the PHQ-9 if concerns are identified Patients should be encouraged to report mood changes between scheduled appointments rather than waiting Self-monitoring can be valuablesome patients find mood tracking apps or journals helpful for identifying patterns Collaborative care approach: Optimal outcomes require coordination between diabetes/weight management teams, primary care, and mental health services when needed
Contact us for personalized healthcare services including weight loss, hormone optimization, and functional medicine.
Start with a comprehensive consultation
Br J Haematol 1955;1:6274